ABSTRACT
Background The COVID pandemic has been a major disruptor of preventive health programs. We set out to establish the burden and control rates of hypertension(HTN) at the dawn of this pandemic, providing baseline reference measures for which the impact of the pandemic on HTN prevalence and control rates can be assessed in future. Methods HTN was classified as mean systolic blood pressure (mSBP) ≥130 mmHg or mean diastolic blood pressure (mDBP) ≥80 mmHg or self-reported current use of antihypertensive medications. Hypertensives on medications with mSBP <130 mmHg and mDBP <80 mmHg were considered as well-controlled. Chi-square test was used in subgroup comparisons of HTN prevalence and p-values <0.05 were considered statistically significant. Results The age-adjusted pre-pandemic prevalence of HTN in the US was 52.3% (50.2-54.3). The prevalence was significantly higher in men: 54.7% (51.6-57.8), Non Hispanic Blacks: 64.8%(62.8-66.9), obese: 62.8%(60.8-64.8) and persons aged ≥ 60years: 77.1%(74.3-79.8). The control rate of HTN was 44.2% (42.0-46.5). There was a statistically significant difference in the rate of control across socioeconomic and racial groups. Conclusion About 52% of individuals ≥20 years in the USA were hypertensives and less than half of them on medications were well-controlled. Significant discrepancies exist in the burden and control rates in different subpopulation categories. Our study calls for more screening for HTN during and especially post COVID pandemic. [Formula presented]
ABSTRACT
In the circumstance of the COVID-19 pandemic, Prevention is better than cure, especially if the cure is not available, the first motto that all health organizations recommend is keep distances between people to prevent epidemic spread. In this paper, an online multi layers social distance detection system is proposed, the main idea is to detect distance among pupils and classify the distance to accept or not, this system treats stream video of fixed camera which monitor the whole school yard where the pupils are available, this proposed system used multi layers, the first is to make person detection using Yolo-4 approach including CNN model, and surround it by rectangle, the second is to specify the center of detected person, finally, calculate the relative distance to decide if it is accepted or not, this system works online and give high accuracy.
ABSTRACT
COVID-19 pandemic, which caused by the newly emerged severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), puts the entire world in an unprecedented crisis, leaving behind huge human losses and serious socio-economical damages. The clinical spectrum of COVID-19 varies from asymptomatic to multi-organ manifestations. Diabetes mellitus (DM) is a chronic inflammatory condition, which associated with metabolic and vascular abnormalities, increases the risk for SARSCoV-2 infection, severity and mortality. Due to global prevalence, DM effect on COVID-19 outcomes as well as the potential mechanisms by which DM modulates the host-viral interactions and host-immune responses are discussed in this review. This review also highlights the effects of anti-diabetic drugs on treatment of SARS-CoV-2 infection and vice versa. [ABSTRACT FROM AUTHOR] Copyright of Journal of Pure & Applied Microbiology is the property of Dr. M. N. Khan and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
ABSTRACT
Introduction In this article we pose the questions of how to manage PDPH in the COVID-19 positive patient and more specifically, the use of epidural blood patch (EBP). EBP in COVID-19 Patients Carries Additional Risks A primary concern in the use of EBP in these patients is the possibility of seeding the virus in the CNS. Another important concern is related to the known hypercoagulable state in COVID-19 positive patients and associated organ dysfunction that may alter the metabolism of anticoagulants. The safety of the providers performing the EBP, the position of the patient and choices for image guidance (blind, fluoroscopic) are also key considerations to review. It is also important to explore the current state of knowledge about using allogenic instead of autologous blood as well as emerging techniques to eliminate the coronavirus from the blood. Other Options for Treating PDPH in COVID-19 Patients EBP is usually considered after the failure of conservative and pharmacological treatments. Because of the additional risks of EBP in COVID-19 patients it is important to also consider less traditional pharmacological treatments such as theophylinnes and cosyntropin that may offer some additional benefit for COVID-19 patient. Finally, other interventions other than EBP should also be considered including occipital nerve blocks, sphenopalatine ganglion blocks (infratemporal or transnasal). Clinical Recommendation We conclude our article with recommendations on how to approach the treatment of PDPH for their COVID-19 patients.